April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Comparing Performance on Cognitive Screening Tests: Individuals With Age-related Macular Degeneration, Glaucoma and Age-matched Controls
Author Affiliations & Notes
  • S. Dubuc
    School of Optometry, University of Montreal, Montreal, Quebec, Canada
  • J. E. S. Gomolin
    Ophthalmology, Jewish General Hospital, McGill University, Quebec, Canada
  • O. Kasner
    Ophthalmology, Jewish General Hospital, McGill University, Quebec, Canada
  • O. Overbury
    School of Optometry, University of Montreal, Montreal, Quebec, Canada
  • Footnotes
    Commercial Relationships  S. Dubuc, None; J.E.S. Gomolin, None; O. Kasner, None; O. Overbury, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 735. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Dubuc, J. E. S. Gomolin, O. Kasner, O. Overbury; Comparing Performance on Cognitive Screening Tests: Individuals With Age-related Macular Degeneration, Glaucoma and Age-matched Controls. Invest. Ophthalmol. Vis. Sci. 2009;50(13):735.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Anatomical studies have shown that the cellular losses and dysfunctions seen in Alzheimer's Disease (AD) demonstrate a similar pathogenesis to the cellular loses and dysfunctions which occur in the presence of retinal diseases, such as Age-related Macular Degeneration (AMD) or glaucoma. Furthermore, a number of studies have recently demonstrated co-morbidity between retinal diseases and pathological cognitive impairment, above what would be expected by chance. However, this co-morbidity with cognitive loss has only been found among individuals with relatively severe vision loss due to AMD and glaucoma. Most often, cognitive testing consists of a modified version of the Mini-Mental State Exam (MMSE), a short screening tool. Recently the MoCA (Montreal Cognitive Assessment) has been developed as an alternative to the MMSE. Although highly correlated with the MMSE, the MoCA may be a more sensitive tool for detecting Mild Cognitive Impairment (MCI), which may precede AD. Both tests are scored out of a possible 30 points and have the same cut-off of 26, a score below this being suggestive of a cognitive impairment. In the present study, the MMSE and the MoCA were compared among individuals with early atrophic AMD, glaucoma and no visual pathology.

Methods: : Number of participants in each group and their respective mean ETDRS acuities OU were: 17 with AMD (20/27), 19 with glaucoma (20/36) and 16 visually healthy people (20/23). Participants ranged in age between 47 and 89, with a mean of 72 years. The MMSE and the MoCA were administered in random order to all participants.

Results: : Chi Square analysis indicated a significantly higher proportion of individuals scoring below the cut-off point of 26 for possible cognitive impairment on the MoCA, chi squared (2) = 32.52 p<.001.

Conclusions: : Given the results of our chi-squared analysis, the MoCA (but not the MMSE) may be detecting the presence of subtle cognitive changes in a population with early progressive retinal disease. Given the suggested co-morbidity between retinal diseases and cognitive impairment, this study may add weight to the possibility that age-related visual disorders and MCI/eventual AD share a common pathogenesis.

Keywords: retina • memory • aging 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×